Clinical Trial Update: Drug Compliance and Quality of Life in Patients With Heart Failure Dosed With Either Once-daily or Twice-daily Coreg [Phase 3]

View source ↗

Summary

This Phase 3 trial update reports on drug compliance and quality of life in chronic heart failure patients treated with carvedilol (Coreg) dosed once daily vers…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Coreg (carvedilol)

Snippet

Sponsor: Cardiovascular Clinical Sciences Inc | Conditions: Chronic Heart Failure | Phase 3 | Status: COMPLETED